Purchases and Sales Made in Q4 2022 in Biomarin Pharmaceutical Inc (BMRN)
This table provides information about the institutional ownership of Biomarin Pharmaceutical Inc (BMRN) during Q4 2022. The information is specifically focused on institutions that hold shares of BIOMARIN PHARMACEUTICAL INC.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2023
Q4 2022
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-26.6K- 27.43% |
$2.15M - $2.89M
|
70.3K
$4.68M
|
|
Feb 06, 2023
Q4 2022
|
Robeco Institutional Asset Management B.V.
|
SELL
|
- |
-27.3K- 47.4% |
$2.21M - $2.96M
|
30.3K
$2.02M
|
|
Feb 14, 2023
Q4 2022
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-27.3K- 29.41% |
$2.21M - $2.96M
|
65.5K
$4.36M
|
|
Feb 09, 2023
Q4 2022
|
Citigroup Inc
|
SELL
|
- |
-33.2K- 15.65% |
$2.68M - $3.6M
|
179K
$11.9M
|
|
Feb 13, 2023
Q4 2022
|
Primecap Management CO
Pasadena, CA |
SELL
|
- |
-44.6K- 0.25% |
$3.61M - $4.85M
|
17.6M
$1.17B
|
|
Feb 13, 2023
Q4 2022
|
Cibc Private Wealth Group, LLC
|
SELL
|
- |
-47.7K- 83.46% |
$3.86M - $5.18M
|
9.45K
$630K
|
|
Feb 14, 2023
Q4 2022
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-47.8K- 19.24% |
$3.87M - $5.2M
|
201K
$13.4M
|
|
Feb 08, 2023
Q4 2022
|
Swiss National Bank
Zurich, V8 |
SELL
|
- |
-48K- 5.99% |
$3.88M - $5.21M
|
754K
$50.2M
|
|
Feb 14, 2023
Q4 2022
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-50K- 22.22% |
$4.05M - $5.43M
|
175K
$11.7M
|
|
Feb 09, 2023
Q4 2022
|
First Trust Advisors LP
Wheaton, IL |
SELL
|
- |
-53.2K- 9.57% |
$4.3M - $5.78M
|
502K
$33.5M
|
|
Jan 26, 2023
Q4 2022
|
Manning & Napier Group, LLC
|
SELL
|
- |
-57.2K- 6.14% |
$4.63M - $6.22M
|
875K
$58.3M
|
|
Feb 09, 2023
Q4 2022
|
Bnp Paribas Asset Management Holding S.A.
|
SELL
|
- |
-60.3K- 35.2% |
$4.88M - $6.55M
|
111K
$7.39M
|
|
Feb 14, 2023
Q4 2022
|
Endurant Capital Management LP
San Mateo, CA |
SELL
|
- |
-61K- 41.97% |
$4.94M - $6.63M
|
84.4K
$5.62M
|
|
Feb 14, 2023
Q4 2022
|
Twinbeech Capital LP
Purchase, NY |
SELL
|
- |
-61.9K- 38.21% |
$5.01M - $6.72M
|
100K
$6.67M
|
|
Feb 14, 2023
Q4 2022
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-63.8K- 5.17% |
$5.16M - $6.93M
|
1.17M
$77.8M
|
|
Jan 30, 2023
Q4 2022
|
New York State Common Retirement Fund
|
SELL
|
- |
-64.9K- 16.98% |
$5.25M - $7.05M
|
317K
$21.1M
|
|
Feb 24, 2023
Q4 2022
|
Natixis
Paris, I0 |
SELL
|
- |
-67.9K- 48.78% |
$5.49M - $7.38M
|
71.3K
$4.75M
|
|
Feb 14, 2023
Q4 2022
|
Amundi
Paris, I0 |
SELL
|
- |
-70.7K- 4.06% |
$5.72M - $7.68M
|
1.67M
$112M
|
|
Feb 10, 2023
Q4 2022
|
Clearbridge Investments, LLC
New York, NY |
SELL
|
- |
-71.4K- 6.08% |
$5.78M - $7.76M
|
1.1M
$73.4M
|
|
Feb 14, 2023
Q4 2022
|
Alyeska Investment Group, L.P.
Chicago, IL |
SELL
|
- |
-74.6K- 12.97% |
$6.04M - $8.1M
|
500K
$33.3M
|
|
Feb 13, 2023
Q4 2022
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-75.6K- 39.01% |
$6.12M - $8.21M
|
118K
$7.88M
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-78.1K- 6.38% |
$6.32M - $8.48M
|
1.15M
$76.3M
|
|
Feb 13, 2023
Q4 2022
|
Natixis
Paris, I0 |
SELL
|
- |
-79.4K- 36.33% |
$6.43M - $8.63M
|
139K
$9.27M
|
|
Feb 14, 2023
Q4 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-80.3K- 29.39% |
$6.5M - $8.72M
|
193K
$12.8M
|
|
Feb 14, 2023
Q4 2022
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-82.9K- 12.98% |
$6.71M - $9M
|
555K
$37M
|
|
Feb 14, 2023
Q4 2022
|
Palo Alto Investors LP
Palo Alto, CA |
SELL
|
- |
-90.5K- 4.58% |
$7.32M - $9.83M
|
1.89M
$126M
|
|
Feb 08, 2023
Q4 2022
|
California Public Employees Retirement System
Sacramento, CA |
SELL
|
- |
-91.7K- 6.92% |
$7.42M - $9.96M
|
1.23M
$82.2M
|
|
Feb 14, 2023
Q4 2022
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
SELL
|
- |
-92.7K- 69.56% |
$7.51M - $10.1M
|
40.6K
$2.7M
|
|
Feb 14, 2023
Q4 2022
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-102K- 5.95% |
$8.26M - $11.1M
|
1.62M
$108M
|
|
Feb 10, 2023
Q4 2022
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-114K- 25.49% |
$9.19M - $12.3M
|
332K
$22.1M
|
|
Feb 13, 2023
Q4 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-114K- 15.34% |
$9.24M - $12.4M
|
630K
$42M
|
|
Feb 14, 2023
Q4 2022
|
Frontier Capital Management CO LLC
|
SELL
|
- |
-147K- 19.38% |
$11.9M - $16M
|
612K
$40.8M
|
|
Feb 14, 2023
Q4 2022
|
Worldquant Millennium Advisors LLC
New York, NY |
SELL
|
- |
-154K- 87.1% |
$12.5M - $16.8M
|
22.9K
$1.52M
|
|
Feb 14, 2023
Q4 2022
|
Axa S.A.
Paris, I0 |
SELL
|
- |
-164K- 28.76% |
$13.3M - $17.9M
|
407K
$27.1M
|
|
Feb 10, 2023
Q4 2022
|
Loomis Sayles & CO L P
|
SELL
|
- |
-188K- 52.84% |
$15.2M - $20.5M
|
168K
$11.2M
|
|
Jan 30, 2023
Q4 2022
|
Parnassus Investments, LLC
|
SELL
|
- |
-228K- 8.87% |
$18.4M - $24.7M
|
2.34M
$156M
|
|
Feb 14, 2023
Q4 2022
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-241K- 5.84% |
$19.5M - $26.2M
|
3.89M
$259M
|
|
Feb 14, 2023
Q4 2022
|
Ubs Asset Management Americas Inc
Chicago, IL |
SELL
|
- |
-261K- 20.45% |
$21.1M - $28.3M
|
1.01M
$67.5M
|
|
Feb 13, 2023
Q4 2022
|
Barclays PLC
London, X0 |
SELL
|
- |
-270K- 12.0% |
$21.9M - $29.4M
|
1.98M
$132M
|
|
Feb 14, 2023
Q4 2022
|
1832 Asset Management L.P.
Toronto, A6 |
SELL
|
- |
-276K- 19.7% |
$22.4M - $30M
|
1.13M
$75M
|
|
Feb 14, 2023
Q4 2022
|
Dodge & Cox
San Francisco, CA |
SELL
|
- |
-390K- 2.64% |
$31.6M - $42.4M
|
14.4M
$958M
|
|
Feb 14, 2023
Q4 2022
|
Health Cor Management, L.P.
New York, NY |
SELL
|
- |
-391K- 51.55% |
$31.7M - $42.5M
|
368K
$24.5M
|
|
Jun 20, 2024
Q4 2022
|
Abrdn PLC
|
SELL
|
- |
-395K- 95.73% |
$32M - $42.9M
|
17.6K
$1.17M
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
SELL
|
- |
-438K- 39.62% |
$35.4M - $47.6M
|
667K
$44.5M
|
|
Mar 06, 2023
Q4 2022
|
Rockefeller Capital Management L.P.
New York, NY |
SELL
|
- |
-492K- 48.3% |
$39.8M - $53.5M
|
527K
$35.1M
|
|
Feb 13, 2023
Q4 2022
|
Senator Investment Group LP
New York, NY |
SELL
|
- |
-500K- 76.92% |
$40.5M - $54.3M
|
150K
$9.99M
|
|
Feb 14, 2023
Q4 2022
|
Deep Track Capital, LP
Greenwich, CT |
SELL
|
- |
-549K- 74.31% |
$44.4M - $59.6M
|
190K
$12.6M
|
|
Feb 14, 2023
Q4 2022
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-578K- 73.58% |
$46.8M - $62.8M
|
208K
$13.8M
|
|
Apr 25, 2023
Q4 2022
|
Victory Capital Management Inc
|
SELL
|
- |
-625K- 82.78% |
$50.6M - $67.9M
|
130K
$8.67M
|
|
Feb 14, 2023
Q4 2022
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-806K- 72.19% |
$65.2M - $87.5M
|
310K
$20.7M
|